XML 65 R47.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation Plans (Tables)
12 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Fair Value Assumptions and Methodology
The fair value of our stock options granted during fiscal 2021, as shown below, was estimated using the Black-Scholes model with the following weighted-average assumptions:
Year Ended September 30,
202120202019
Weighted-average grant date fair value$51.92 $39.68 $27.34 
Expected term (in years)6.746.966.86
Expected volatility40 %32 %26 %
Risk-free rate of return0.7 %1.6 %2.8 %
Dividend yield1.2 %1.3 %1.6 %
A summary of stock option activity is as follows:
Stock OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value
(in thousands)
Outstanding at September 30, 2020807 $75.87 
Granted113 147.67 
Exercised(132)54.34 
Forfeited or canceled(9)107.33 
Outstanding at September 30, 2021779 89.61 6.0$29,654 
Exercisable at September 30, 2021510 $69.52 4.9$27,763 
Expected to vest at September 30, 2021269 $127.60 8.1$1,891 
Year Ended September 30,
202120202019
Intrinsic value of options exercised$14,640 $19,077 $20,711 
Cash received from exercise of options7,190 9,350 13,193 
Tax benefit from exercise of options2,848 3,629 4,449 
Fair value of options vested3,892 3,765 4,506 
Summary of Restricted Stock Awards and Restricted Stock Unit Awards
A summary of the activity of the restricted stock awards, RSU awards, and PSU awards is presented below:
Restricted Stock Awards and Units1
Weighted Average Grant Date Fair Value
Nonvested at September 30, 2020257 $104.83 
Granted2
101 141.70 
Vested(117)95.82 
Forfeited(8)118.64 
Nonvested at September 30, 2021233 126.61 
1.Includes PSUs.
2.Includes additional PSUs earned relating to the fiscal 2018 grant based on final performance factor.
Year Ended September 30,
202120202019
Weighted average grant date fair value$126.61 $104.83 $87.36 
Total fair value of restricted stock awards and units vested$11,702 $7,481 $11,060 
Share Based Compensation Expense
Total share-based compensation expense and the classification of that expense in the Consolidated Statements of (Loss) Income is as follows:
Year Ended September 30,
202120202019
Cost of sales$2,970 $2,863 $2,727 
Research, development and technical1,739 2,090 2,150 
Selling, general and administrative14,969 11,443 13,350 
Tax benefit(3,755)(3,162)(3,767)
Total share-based compensation expense, net of tax$15,923 $13,234 $14,460 
Total gross share-based compensation expense is attributable to the following awards:
Year Ended September 30,
202120202019
Stock Options$4,722 $4,406 $4,267 
Restricted stock awards and restricted stock units8,754 8,259 11,400 
Performance share units3,662 1,957 1,279 
ESPP2,540 1,774 1,281